Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Gakhar, Gunjan ^a   Navarro, Vicente N ^a   Jurish, Madelyn ^a   Lee, Guang Yu ^a   Tagawa, Scott T ^a   Akhtar, Naveed H ^a   Seandel, Marco ^a   Geng, Yue ^b   Liu, He ^a   Bander, Neil H ^a   Giannakakou, Paraskevi ^a   Christos, Paul J ^a   King, Michael R ^b   Nanus, David M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR PROTEIN;

BLOOD FLOW VELOCITY; CELL LINE; CLINICAL TRIAL; HUMAN; MALE; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGICAL STRESS; PROSTATE TUMOR; TUMOR EMBOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

BLOOD FLOW VELOCITY; CELL LINE; E-SELECTIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; STRESS, PHYSIOLOGICAL;

EID: 84893592857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085143     Document Type: Article

References (54)

1. Läubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20: 169-177. doi:10.1016/j.semcancer.2010.04.005. PubMed: 20452433.
2. Lawrence MB, Springer TA (1991) Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 65: 859-873. doi:10.1016/0092-8674(91)90393-D. PubMed: 1710173. (Pubitemid 121001317)
3. Petri B, Phillipson M, Kubes P (2008) The physiology of leukocyte recruitment: An in vivo perspective. J Immunol 180: 6439-6446. PubMed: 18453558.
4. Laferriere J, Houle F, Taher MM, Valerie K, Huot J (2001) Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 276: 33762-33772. doi:10.1074/jbc.M008564200. PubMed: 11448946.
5. Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P (2002) Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62: 5393-5398. PubMed: 12359742.
6. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S et al. (1999) Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59: 1356-1361. PubMed: 10096570. (Pubitemid 29136269)
7. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I (1996) Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 183: 581-587. doi:10.1084/jem.183.2.581. PubMed: 8627169. (Pubitemid 26060792)
8. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60: 3978-3984. PubMed: 10919677. (Pubitemid 32204595)
9. Köhler S, Ullrich S, Richter U, Schumacher U (2010) E-/P-selectins and colon carcinoma metastasis: First in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer 102: 602-609. doi:10.1038/sj.bjc.6605492. PubMed: 20010946.
10. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R (2001) CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153: 1277-1286. doi:10.1083/jcb.153.6.1277. PubMed: 11402070. (Pubitemid 34289265)
11. Sackstein R, Dimitroff CJ (2000) A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood 96: 2765-2774. PubMed: 11023510.
12. Idikio HA (1997) Sialyl-lewis-X, gleason grade and stage in non-metastatic human prostate cancer. Glycoconj J 14: 875-877. doi:10.1023/A:1018502424487. PubMed: 9511995.
13. Kannagi R (2004) Molecular mechanism for cancer-associated induction of sialyl lewis X and sialyl lewis A expression-the warburg effect revisited. Glycoconj J 20: 353-364. PubMed: 15229399.
14. Barthel SR, Hays DL, Yazawa EM, Opperman M, Walley KC et al. (2013) Definition of molecular determinants of prostate cancer cell bone extravasation. Cancer Res 73: 942-952. doi:10.1158/0008-5472.CAN-12-3264. PubMed: 23149920.
15. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A et al. (1997) Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 57: 3629-3634. PubMed: 9288760. (Pubitemid 27381196)
16. Hughes AD, Mattison J, Western LT, Powderly JD, Greene BT et al. (2012) Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem 58: 846-853. doi:10.1373/clinchem.2011.176669. PubMed: 22344286.
17. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL (2004) Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64: 5261-5269. doi:10.1158/0008-5472.CAN-04-0691. PubMed: 15289332. (Pubitemid 39006546)
18. Seandel M, Butler JM, Kobayashi H, Hooper AT, White IA et al. (2008) Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc Natl Acad Sci U S A 105: 19288-19293. doi:10.1073/pnas.0805980105. PubMed: 19036927.
19. Lee D, Schultz JB, Knauf PA, King MR (2007) Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl lewis x under flow. J Biol Chem 282: 4812-4820. PubMed: 17172469. (Pubitemid 47100965)
20. del Pozo MA, Alderson NB, Grande-GarcÃa A, Balasubramanian N, Schwartz MA et al. (2005) Phospho-caveolin-1 mediates integrin-regulated membrane domain internalisation. Nat Cell Biol 7: 901-908. doi:10.1038/ncb1293. PubMed: 16113676. (Pubitemid 41486291)
21. Tagawa ST, Milowsky MI, Morris MJ, Vallabhajosula S, Christos PJ et al. (2013) Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res 19: 5182-5191. doi:10.1158/1078-0432.CCR-13- 0231. PubMed: 23714732.
22. Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D et al. (2009) Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 15: 167-172. doi:10.1007/s12253-008-9104-2. PubMed: 18802790.
23. Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S et al. (1998) Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res 58: 4055-4060. PubMed: 9751609. (Pubitemid 28440554)
24. Hsu JW, Yasmin-Karim S, King MR, Wojciechowski JC, Mickelsen D et al. (2011) Suppression of prostate cancer cell rolling and adhesion to endothelium by 1alpha,25-dihydroxyvitamin D3. Am J Pathol 178: 872-880. doi:10.1016/j. ajpath.2010.10.036. PubMed: 21281819.
25. Yin X, Rana K, Ponmudi V, King MR (2010) Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res 345: 2334-2342. doi:10.1016/j.carres.2010.07.028. PubMed: 20833389.
26. Remuzzi A, Giavazzi R (1999) Adhesion of tumor cells under flow. In: E DejanaM Corada. Adhesion Protein Protocols. New Jersey: Humana Press. pp. 153-157.
27. Kim MB, Sarelius IH (2004) Regulation of leukocyte recruitment by local wall shear rate and leukocyte delivery. Microcirculation 11: 55-67. doi:10.1080/10739680490266199. PubMed: 15280097. (Pubitemid 39618606)
28. Dimitroff CJ, Descheny L, Trujillo N, Kim R, Nguyen V et al. (2005) Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65: 5750-5760. doi:10.1158/0008-5472.CAN-04-4653. PubMed: 15994950. (Pubitemid 40911178)
29. Xing Y, Liu M, Du Y, Qu F, Li Y et al. (2008) Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach. Cancer Biol Ther 7: 1839-1848. doi:10.4161/cbt.7.11.6862. PubMed: 18836306.
30. Konstantopoulos K, Thomas SN (2009) Cancer cells in transit: The vascular interactions of tumor cells. Annu Rev Biomed Eng 11: 177-202. doi:10.1146/annurev-bioeng-061008-124949. PubMed: 19413512.
31. Rahman A, Kefer J, Bando M, Niles WD, Malik AB (1998) E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol 275: L533-L544. PubMed: 9728048.
32. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B (1989) Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243: 1160-1165. doi:10.1126/science.2466335. PubMed: 2466335. (Pubitemid 19081142)
33. Conant CG, Nevill JT, Zhou Z, Dong JF, Schwartz MA et al. (2011) Using well-plate microfluidic devices to conduct shear-based thrombosis assays. J Lab Autom 16: 148-152. doi:10.1016/j.jala.2010.10.005. PubMed: 21609696.
34. Rana K, Liesveld JL, King MR (2009) Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng 102: 1692-1702. doi:10.1002/bit.22204. PubMed: 19073014.
35. Rana K, Reinhart-King CA, King MR (2012) Inducing apoptosis in rolling cancer cells: A combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm 9: 2219-2227. PubMed: 22724630.
36. Burdick MM, Chu JT, Godar S, Sackstein R (2006) HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281: 13899-13905. doi:10.1074/jbc.M513617200. PubMed: 16565092. (Pubitemid 43848314)
37. Tremblay PL, Auger FA, Huot J (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25: 6563-6573. doi:10.1038/sj.onc.1209664. PubMed: 16715142. (Pubitemid 44646184)
38. Akhtar NH, Pail O, Saran A, Tyrell L, Tagawa ST. (2012) Prostate-specific membrane antigen-based therapeutics. Adv Urol 2012: 973820
39. Osborne JR, Akhtar NH, Vallabhajosula S, Anand A, Deh K et al. (2013) Prostate-specific membrane antigen-based imaging. Urol Oncol 31: 144-154. doi:10.1016/j.urolonc.2012.04.016. PubMed: 22658884.
40. Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D et al. (2011) Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res 71: 6019-6029. doi:10.1158/0008-5472.CAN-11-1417. PubMed: 21799031.
41. Miyamoto DT, Lee RJ, Stott SL, Ting DT, Wittner BS et al. (2012) Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov 2: 995-1003. Available online at: doi:10.1158/2159-8290.CD-12-0222 PubMed: 23093251.
42. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K (2003) Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 284: C977-C987. doi:10.1152/ajpcell.00423.2002. PubMed: 12477667. (Pubitemid 36336954)
43. Giavazzi R, Foppolo M, Dossi R, Remuzzi A (1993) Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 92: 3038-3044. doi:10.1172/JCI116928. PubMed: 7504697. (Pubitemid 24006576)
44. Kitayama J, Tsuno N, Sunami E, Osada T, Muto T et al. (2000) E-selectin can mediate the arrest type of adhesion of colon cancer cells under physiological shear flow. Eur J Cancer 36: 121-127. doi:10.1016/S0959-8049(99) 00228-2. PubMed: 10741305. (Pubitemid 30035354)
45. Sawada R, Tsuboi S, Fukuda M (1994) Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 269: 1425-1431. PubMed: 7507108.
46. Tremblay PL, Huot J, Auger FA (2008) Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res 68: 5167-5176. doi:10.1158/0008-5472.CAN-08-1229. PubMed: 18593916.
47. Rossiter H, van Reijsen F, Mudde GC, Kalthoff F, Bruijnzeel-Koomen CA et al. (1994) Skin disease-related T cells bind to endothelial selectins: Expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol 24: 205-210. doi:10.1002/eji.1830240132. PubMed: 7517361. (Pubitemid 24014700)
48. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS (1997) Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389: 978-981. doi:10.1038/40166. PubMed: 9353122. (Pubitemid 27485690)
49. Barthel SR, Gavino JD, Descheny L, Dimitroff CJ (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11: 1473-1491. doi:10.1517/14728222.11.11.1473. PubMed: 18028011.
50. Inaba Y, Ohyama C, Kato T, Satoh M, Saito H et al. (2003) Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells. Int J Cancer 107: 949-957. doi:10.1002/ijc.11513. PubMed: 14601054. (Pubitemid 37429836)
51. Barthel SR, Wiese GK, Cho J, Opperman MJ, Hays DL et al. (2009) Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A 106: 19491-19496. doi:10.1073/pnas.0906074106. PubMed: 19889975.
52. Barthel SR, Gavino JD, Wiese GK, Jaynes JM, Siddiqui J et al. (2008) Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology 18: 806-817. doi:10.1093/glycob/cwn070. PubMed: 18647941.
53. Wang J, Loberg R, Taichman RS (2006) The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25: 573-587. PubMed: 17165132. (Pubitemid 46071864)
54. Fusi A, Liu Z, Kümmerlen V, Nonnemacher A, Jeske J et al. (2012) Expression of chemokine receptors on circulating tumor cells in patients with solid tumors. J Transl Med 10: 52-5876-10-52. PubMed: 22433180.